NASDAQ
Liminal BioSciences Inc. (LMNL) has a free cash flow growth of 24.78% as of Friday, May 29, 2026. This represents a 213.95% increase compared to its 12-month average of -21.75%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.